Area of research
Hematology · Hepatology
Research interest
Research interests include Blood Coagulation and Thrombosis Mechanisms, Liver Disease and Transplantation, Venous Thromboembolism Diagnosis and Management, and Liver Disease Diagnosis and Treatment.
Impaired whole blood thrombin generation is associated with procedure-related bleeding in acutely decompensated cirrhosis
Whole blood thrombin generation shows a significant hypocoagulable state in patients with decompensated cirrhosis
Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis
Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death
Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections
Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19
Thrombin generation in patients with COVID-19 with and without thromboprophylaxis
Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute‐on‐chronic liver failure
Influence of Hepatocellular Carcinoma on Platelet Aggregation in Cirrhosis
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study
Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo‐coagulable and Hyper‐coagulable Features
Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease
Endothelial Damage of the Portal Vein is Associated with Heparin-Like Effect in Advanced Stages of Cirrhosis
Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study
Partial <i>F8</i> gene duplication (factor VIII Padua) associated with high factor VIII levels and familial thrombophilia
Reversal of hypercoagulability in patients with <scp>HCV</scp>‐related cirrhosis after treatment with direct‐acting antivirals
“In vitro” correction of the severe factor V deficiency‐related coagulopathy by a novel plasma‐derived factor V concentrate
New Prothrombin Mutation (Arg596Trp, Prothrombin Padua 2) Associated With Venous Thromboembolism
Dynamics of circulating microparticles in obesity after weight loss
Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis
Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome
The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein I antibodies. A comparison with a homemade ELISA method
Increased anticoagulant response to low‐molecular‐weight heparin in plasma from patients with advanced cirrhosis